Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
21
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
28 Apr 2017 14:09
The Week That Was in NorthAsia@Smartkarma - THAAD Deployment, Mobile Lineage, and Activism in Japan
KoreaScott Laprise/ 乐天虎 and Prasenjit K. Basu have provided great insights regarding the political turmoil surrounding North Korea. Scott makes it...
Douglas Kim
Follow
239 Views
Share
bearish
•
Cross Asset Strategy
•
28 Apr 2017 05:42
EM Managers - Most Avoided Stocks
• The 830 stocks in the benchmark MSCI Emerging Market Index all represent legitimate investments for global EM active managers. Whilst publicly...
Steven Holden
Follow
340 Views
Share
bearish
•
Celltrion Inc
•
22 Apr 2017 02:17
The Disconnect Is Growing
Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...
Kemp Dolliver, CFA
607 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 Mar 2017 23:38
Alpha Generation from Share Buybacks in Korea (2017 YTD)
In this report, we have identified 26 stocks in the Korean stock market that have announced share buyback programs so far in 2017. These stocks...
Douglas Kim
Follow
1.3k Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Mar 2017 10:59
Update on the Put Back Option Clause for IPOs in the Korea Stock Market
This report is an update on the implementation of the "put-back option clause" for IPOs in the Korea Stock Market (for companies applying under the...
Douglas Kim
Follow
400 Views
Share
First
Previous
82
83
84
85
86
87
88
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.37.2
x